Close Menu

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Pacific Biosciences will make 12.5 million shares available at a price between $15 and $17 per share for its initial public offering, the company said in an amended preliminary prospectus filed with the US Securities Exchanged Commission today.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Wall Street Journal reports on the struggle to meet the demand for rapid COVID-19 testing.

The Newsroom reports New Zealand is using genomics to trace the origins of its new coronavirus outbreak.

In Nature this week: researchers in Canada sequence the genome of the black mustard plant Brassica nigra, and more.

According to Bloomberg, Moderna has a $1.5 billion vaccine deal with the US to provide 100 million doses.